All-trans retinoic acid and gemtuzumab ozogamicin as adjunct to high-dose cytarabine-based salvage therapy in primary refractory acute myeloid leukemia: Results of AMLSG 05-04 trial

Dokumenttyp:: Meeting Abstract
Autor(en):: Schlenk, RF; Döhner, K; Krauter, J; Späth, D; De Valle, F; Heydrich, B; Horst, HA; Schmidt-Wolf, I; Rummel, M; Götze, K; Koller, E; Petzer, A; Mergenthaler, HG; Salwender, H; Fiedler, W; Kirchen, H; Haase, D; Kramers, S; Theobald, M; Matzdorff, AC; Ganser, A; Duhner, H
Titel:: All-trans retinoic acid and gemtuzumab ozogamicin as adjunct to high-dose cytarabine-based salvage therapy in primary refractory acute myeloid leukemia: Results of AMLSG 05-04 trial
Zeitschriftentitel:: Blood
Jahr:: 2007
Band / Volume:: 110
Heft / Issue:: 11
Seitenangaben Beitrag:: 544A-544A
Sprache:: eng
Print-ISSN:: 0006-4971
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: